These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26728544)

  • 1. Active Versus Passive Anchoring Vascular Closure Devices Following Percutaneous Coronary Intervention: A Safety and Efficacy Comparative Analysis.
    Baker NC; Escarcega RO; Lipinski MJ; Magalhaes MA; Koifman E; Kiramijyan S; Negi SI; Torguson R; Waksman R
    J Interv Cardiol; 2016 Feb; 29(1):108-12. PubMed ID: 26728544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular complications after percutaneous coronary intervention following hemostasis with the Mynx vascular closure device versus the AngioSeal vascular closure device.
    Azmoon S; Pucillo AL; Aronow WS; Ebrahimi R; Vozzolo J; Rajdev A; Kalapatapu K; Ro JH; Hjemdahl-Monsen C
    J Invasive Cardiol; 2010 Apr; 22(4):175-8. PubMed ID: 20351388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Review of Randomized Controlled Trials Comparing Manual Compression to Vascular Closure Devices for Diagnostic and Therapeutic Arterial Procedures.
    Cox T; Blair L; Huntington C; Lincourt A; Sing R; Heniford BT
    Surg Technol Int; 2015 Nov; 27():32-44. PubMed ID: 26680377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of radial, brachial, and femoral accesses using hemostatic devices for percutaneous coronary intervention.
    Otsuka M; Shiode N; Nakao Y; Ikegami Y; Kobayashi Y; Takeuchi A; Harima A; Higaki T; Oi K; Dai K; Kawase T; Nakama Y; Suenari K; Nishioka K; Sakai K; Shimatani Y; Masaoka Y; Inoue I
    Cardiovasc Interv Ther; 2018 Jan; 33(1):62-69. PubMed ID: 27830459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AbsorbaSeal™ Vascular Closure Device: A Novel Device for Hemostasis Following Interventional Peripheral Vascular Procedures.
    Benham E; Deloose K; Callaert J; Bosiers M; Cox T; Lincourt A; Heniford BT
    Surg Technol Int; 2017 Oct; 31():93-99. PubMed ID: 29020709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mynx Vascular Closure Device in Arterial Endovascular Procedures.
    Scott MC; Spencer HJ; Ali AT; Moursi MM; Escobar GA; Lyons LC; Smeds MR
    Ann Vasc Surg; 2018 Jan; 46():112-117. PubMed ID: 28546043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative safety of vascular closure devices and manual closure among patients having percutaneous coronary intervention.
    Gurm HS; Hosman C; Share D; Moscucci M; Hansen BB;
    Ann Intern Med; 2013 Nov; 159(10):660-6. PubMed ID: 24247671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of using vascular closure devices for hemostasis on sheath removal after a transfemoral artery percutaneous coronary intervention.
    Su SF; Chang MY; Wu MS; Liao YC
    Jpn J Nurs Sci; 2019 Apr; 16(2):172-183. PubMed ID: 30044037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Subclinical Femoral Vascular Complications after Deployment of two Different Vascular Closure Devices or Manual Compression in the Setting of Coronary Intervention.
    Yeni H; Axel M; Örnek A; Butz T; Maagh P; Plehn G
    Int J Med Sci; 2016; 13(4):255-9. PubMed ID: 27076781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the FemoSeal Vascular Closure Device With Manual Compression After Femoral Artery Puncture - Post-hoc Analysis of a Large-Scale, Randomized Clinical Trial.
    Mankerious N; Mayer K; Gewalt SM; Helde SM; Ibrahim T; Bott-Flügel L; Laugwitz KL; Schunkert H; Kastrati A; Schüpke S;
    J Invasive Cardiol; 2018 Jul; 30(7):235-239. PubMed ID: 29760286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extravascular compared to Intravascular Femoral Closure is Associated with Less Bleeding and Similar MACE after Percutaneous Coronary Intervention.
    Kim SH; Behnes M; Baron S; Shchetynska-Marinova T; Uensal M; Mashayekhi K; Hoffmann U; Borggrefe M; Akin I
    Int J Med Sci; 2019; 16(1):43-50. PubMed ID: 30662327
    [No Abstract]   [Full Text] [Related]  

  • 12. Collagen plug vascular closure devices and reduced risk of bleeding with bivalirudin versus heparin plus abciximab in patients undergoing percutaneous coronary intervention for non st-segment elevation myocardial infarction.
    Leibundgut G; Pache J; Schulz S; Berger PB; Ferenc M; Gick M; Mehilli J; Kastrati A; Neumann FJ
    J Interv Cardiol; 2013 Dec; 26(6):623-9. PubMed ID: 24118114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Safety and Efficacy of Unfractionated Heparin Versus Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention.
    Rehmani A; Judkins C; Whelan A; Nguyen M; Schultz C
    Heart Lung Circ; 2017 Dec; 26(12):1277-1281. PubMed ID: 28377232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FemoSeal
    Gabrielli R; Rosati MS; Millarelli M; Dante A; Maiorano M; Musilli A; Chiappa R; Ventura M
    Ann Vasc Surg; 2018 Aug; 51():18-24. PubMed ID: 29678650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro).
    Chamberlin JR; Lardi AB; McKeever LS; Wang MH; Ramadurai G; Grunenwald P; Towne WP; Grassman ED; Leya FS; Lewis BE; Stein LH
    Catheter Cardiovasc Interv; 1999 Jun; 47(2):143-7; discussion 148. PubMed ID: 10376492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention.
    Marquis-Gravel G; Boivin-Proulx LA; Huang Z; Zelenkofske SL; Lincoff AM; Mehran R; Steg PG; Bode C; Alexander JH; Povsic TJ
    J Am Heart Assoc; 2023 Jan; 12(1):e025666. PubMed ID: 36583436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of angiographic femoral artery complications after vascular closure with Mynx and AngioSeal.
    Fargen KM; Velat GJ; Lawson MF; Ritchie CA; Firment C; Hoh BL; Bennett JA; Mocco J
    J Neurointerv Surg; 2013 Mar; 5(2):161-4. PubMed ID: 22266794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of radial access versus femoral access with the use of a vascular closure device for the prevention of vascular complications and mortality after percutaneous coronary intervention.
    Téblick A; Vanderbruggen W; Vandendriessche T; Bosmans J; Haine SEF; Miljoen H; Segers V; Wouters K; Vrints C; Claeys MJ
    Acta Cardiol; 2018 Jun; 73(3):241-247. PubMed ID: 28851255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel.
    Exaire JE; Tcheng JE; Kereiakes DJ; Kleiman NS; Applegate RJ; Moliterno DJ;
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):369-72. PubMed ID: 15736260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Arterial Closure Devices in an Office-Based Angiosuite.
    Jones LE; Yang KH; Feldtman RW; Uceda PV; Ferrara CA; Caruso JM; Richmond JL; Ahn SS
    Ann Vasc Surg; 2018 Aug; 51():10-17. PubMed ID: 29655814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.